Dr. Richard J. Hodes, Director of the National Institute on Aging/NIH, discusses selected highlights from the 2013 – 2014 Alzheimer’s Disease Progress Report.
Pfizer, the world’s third-largest pharmaceutical company, recently announced that it is abandoning research for Alzheimer’s and Parkinson’s disease treatments. The decision, which will lay off hundreds of research positions throughout the pharmaceutical titan, crushes the hopes of millions suffering from these neurological disorders, and now their dreams of finding a medication won’t likely come to […]
American singer Glen campbell died at 81 | Aerft Battle With Alzheimer’s Disease | Pop Singer American singer Glen campbell died at 81 | Aerft Battle With Alzheimer’s Disease | Pop Singer American singer Glen campbell died at 81 | Aerft Battle With Alzheimer’s Disease | Pop Singer
Mental Health – Mental Health Documentary – Drink This To Reduce Your Alzheimer’s Risk By 86%./ f you love tea, then consider “tea time” as a way to drink to your health. As long as its tea brewed from tea leaves and you consume it regularly, you can reduce the risk of Alzheimer’s. So how […]
Curing Alzheimer’s: BBC Horizon Documentary
Dr. Laurie Ryan of the Division of Neuroscience at the National Institute on Aging/NIH describes how clinical trials are advancing Alzheimer’s research.
Suzana Petanceska, Ph.D., of the National Institute on Aging discusses Alzheimer’s disease translational research
Dr. Richard J. Hodes, Director of the National Institute on Aging/NIH, welcomes viewers to the 2012-2013 Alzheimer’s Disease Progress Report: Seeking the Earliest Interventions, an annual overview of Federally-funded Alzheimer’s disease research efforts.
Recommendations from the NIH-hosted Alzheimer’s Disease-Related Dementias: Research Challenges and Opportunities meeting in May, 2013 will shape research priorities for years to come.
Dr. Neil Buckholtz, Director of the Division of Neuroscience at the National Institute on Aging/NIH, describes how biomarkers—in blood, cerebrospinal fluid and brain imaging—are advancing our ability to detect the earliest stages of Alzheimer’s, track its progression, and determine the effectiveness of promising treatments.
Dr. Thomas Obisesan describes the ADNI study which he directs at Howard University.
Warner, a clinical trial volunteer, describes his participation in the Alzheimer’s Disease Neuroimaging Initiative (ADNI).
This is an overview of the Alzheimer’s Disease Research Summit held at the National Institutes of Health (NIH) in May, 2012.
Dr. Dewayne Nash has a strong family history of Alzheimer’s disease and he’s always known that it could be in his future. So, he decided to volunteer for a study at UT Southwestern’s Alzheimer’s Disease Center where he could contribute to research efforts and be monitored for signs of cognitive impairment. His decision to volunteer changed his life and set him on a new course. Here is his story.
Laurie Ryan, Ph.D., of the National Institute on Aging Discusses the Alzheimer’s Disease Neuroimaging Initiative